StonvexLoading…
StonvexStonvexStonvexCore line items from FRPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $10.59M | $42.85M | $31.93M | $21.16M |
Operating Income | $512.00K | $7.03M | $5.34M | $3.98M |
Net Income | $-687.00K | $3.33M | $2.95M | $2.29M |
EPS (Diluted) | $-0.04 | $0.18 | $0.16 | $0.12 |
Total Assets | $750.39M | $735.14M | $731.26M | $722.78M |
Total Liabilities | $295.99M | $279.49M | $269.06M | $261.37M |
Cash & Equivalents | $107.86M | $105.36M | $134.85M | $153.17M |
Free Cash Flow OCF − CapEx | $-3.75M | $-21.46M | $-12.90M | $4.01M |
Shares Outstanding | 19.17M | 19.11M | 19.11M | 19.11M |